|
FXC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.96000999999058E-05 |
| Normal-vs-Stage3 |
2.28079999331499E-10 |
| Normal-vs-Stage4 |
6.34559960133174E-10 |
| Stage1-vs-Stage2 |
4.629400E-01 |
| Stage1-vs-Stage3 |
8.893000E-01 |
| Stage1-vs-Stage4 |
6.320800E-01 |
| Stage2-vs-Stage3 |
5.934400E-01 |
| Stage2-vs-Stage4 |
3.714200E-01 |
| Stage3-vs-Stage4 |
5.385000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.1917584654766E-12 |
| Normal-vs-Asian |
4.19380000005187E-06 |
| Caucasian-vs-AfricanAmerican |
1.599040E-01 |
| Caucasian-vs-Asian |
9.552600E-01 |
| AfricanAmerican-vs-Asian |
6.912200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
7.43870520736323E-11 |
| Male-vs-Female |
1.990190E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.86639592669735E-11 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
2.77555756156289E-15 |
| Normal-vs-Extreme_Obese |
5.766600E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.241600E-01 |
| Normal_Weight-vs-Obese |
9.644000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.406800E-01 |
| Extreme_Weight-vs-Obese |
2.716800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.455000E-01 |
| Obese-vs-Extreme_Obese |
7.224400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.27720000131504E-08 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
2.83379986143473E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.363800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.756000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.076400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.780000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.627900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.710610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
5.82867087928207E-14 |
| Normal-VS-KIRP CIMP |
2.23099999996368E-06 |
| Normal-VS-Unclassified PRCC |
1.33809999969259E-07 |
| Type1 PRCC-VS-Type2 PRCC |
6.862400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.518200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.162040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.100400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.680600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.734200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.31006316905768E-13 |
| Normal-vs-N2 |
3.899799999596E-07 |
| N0-vs-N1 |
8.580200E-01 |
| N0-vs-N2 |
5.035000E-01 |
| N1-vs-N2 |
3.882400E-01 |
|
|
